Trop-2 as an Actionable Biomarker in Breast Cancer-Reference-Cited by-同舟云学术

Trop-2 as an Actionable Biomarker in Breast Cancer

Published:2023-05 Issue:3 Volume:24 Page:129-131
ISSN:1389-2029
Container-title:Current Genomics
language:en
Short-container-title:CG

Author:

Cursano Giulia¹^ORCID,Frigo Emanuele¹²,Sajjadi Elham¹³^ORCID,Ivanova Mariia¹^ORCID,Venetis Konstantinos¹^ORCID,Guerini-Rocco Elena¹³^ORCID,Criscitiello Carmen³⁴^ORCID,Curigliano Giuseppe³⁴,Fusco Nicola¹³^ORCID

Affiliation:

1. Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy

2. School of Pathology, University of Milan, Milan, Italy

3. Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy

4. Division of New Drugs and Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy

Abstract

Publisher

Bentham Science Publishers Ltd.

Subject

Genetics (clinical),Genetics

Reference20 articles.

1. Goldenberg D.M.; Stein R.; Sharkey R.M.; The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target. Oncotarget 2018,9(48),28989-29006

2. Vranic S.; Palazzo J.; Sanati S.; Florento E.; Contreras E.; Xiu J.; Swensen J.; Gatalica Z.; Potential novel therapy targets in neuroendocrine carcinomas of the breast. Clin Breast Cancer 2019,19(2),131-136

3. Zeng P.; Chen M.B.; Zhou L.N.; Tang M.; Liu C.Y.; Lu P.H.; Impact of TROP2 expression on prognosis in solid tumors: A systematic review and meta-analysis. Sci Rep 2016,6(1),33658

4. Vidula N.; Yau C.; Rugo H.S.; Trop2 gene expression (Trop2e) in primary breast cancer (BC): Correlations with clinical and tumor characteristics. J Clin Oncol 2023,35(S15),1075-1075

5. Jeon Y.; Jo U.; Hong J.; Gong G.; Lee H.J.; Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer. BMC Cancer 2022,22(1),1014